Your session is about to expire
← Back to Search
Dexamethasone-Eluting Cochlear Implant for Hearing Loss
Study Summary
This trial looks at whether a cochlear implant that elutes dexamethasone can help reduce inflammation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I am 18 years old or older.I am not pregnant and do not plan to become pregnant.My inner and middle ear structures are not typical.You are allergic to dexamethasone.I have had cochlear implant surgery.I have severe hearing loss in both ears, worse in high frequencies.I have severe hearing loss in both ears, worse in high frequencies.
- Group 1: CI632D Investigational Medical Device (IMD)
- Group 2: CI632 Comparator Device
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current number of participants involved in this experiment?
"If eligible, 120 individuals are required to sign up for this clinical trial. Those interested can join from New york Eye & Ear infirmary of Mt. Sinai in New York or University of California Los Angeles(UCLA), Medical center in Los Angeles."
Are there a great many locations in Canada currently involved with this investigation?
"This trial is presently conducted in 16 sites, with presence spread across major cities like New york, Los Angeles and Ann Arbor. It may be useful to choose a nearby location to reduce travelling if you decide to partake in this study."
Are there any remaining vacancies for participants in this experiment?
"Indeed, the clinicaltrial.gov website reveals that enrollment for this trial is currently ongoing. This research initiative was first unveiled on October 4th 2021 and has been up to date as of October 21st 2022. 120 participants are needed from 16 different medical facilities."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger